Suppression of Ovarian Cancer Cell Proliferation Is Associated with Upregulation of Cell-Matrix Adhesion Programs and Integrin-β4-Induced Cell Protection from Cisplatin.
Sadaf Farsinejad, Daniel Centeno, Jan Savas-Carstens, Teagan Polotaye, Tonja Pavlovič, Pouria Babvey, Taru Muranen, Cezary Miedziarek, Piotr Jasiński, Elżbieta Dziabaszewska and 4 more
Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Sadaf FarsinejadDepartment of Chemistry and Chemical Biology, Stevens Institute of Technology, Hoboken, NJ 07030, USA.
Daniel CentenoDepartment of Chemistry and Chemical Biology, Stevens Institute of Technology, Hoboken, NJ 07030, USA.
Jan Savas-CarstensNew York Stem Cell Foundation Research Institute, New York, NY 10019, USA.
Teagan PolotayeDepartment of Chemistry and Chemical Biology, Stevens Institute of Technology, Hoboken, NJ 07030, USA.ORCID 0009-0006-3566-4570
Tonja PavlovičDepartment of Chemistry and Chemical Biology, Stevens Institute of Technology, Hoboken, NJ 07030, USA.ORCID 0000-0002-1165-4013
Pouria BabveySchool of Systems and Enterprises, Stevens Institute of Technology, Hoboken, NJ 07030, USA.
Taru MuranenDepartment of Medicine, Cancer Research Institute, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.ORCID 0000-0003-4158-9002
Cezary MiedziarekDepartment of Gynecologic Oncology, Chair of Gynecology, Poznań, University of Medical Sciences, 33 Polna Street, 60-535 Poznań, Poland.
Piotr JasińskiDepartment of Pathology in Obstetrics and Gynecology Hospital, Poznań, University of Medical Sciences, Polna 33, 60-535 Poznań, Poland.
Elżbieta DziabaszewskaDepartment of Pathology in Obstetrics and Gynecology Hospital, Poznań, University of Medical Sciences, Polna 33, 60-535 Poznań, Poland.
Mikołaj Piotr ZaborowskiDepartment of Gynecologic Oncology, Chair of Gynecology, Poznań, University of Medical Sciences, 33 Polna Street, 60-535 Poznań, Poland.ORCID 0000-0002-4400-6688
Laura A MartinNew York Stem Cell Foundation Research Institute, New York, NY 10019, USA.ORCID 0000-0003-2677-1025
Marcin P IwanickiDepartment of Chemistry and Chemical Biology, Stevens Institute of Technology, Hoboken, NJ 07030, USA.ORCID 0000-0001-8375-8447
Funding
Establishing efficient technologies for ovarian cancer organoid derivation from fresh tumor resectionsR21CA240219 · NCI · NEW YORK STEM CELL FOUNDATION · PI ANDRES-MARTIN, LAURA · 2019 to 2021
$626k
High-Resolution Dynamic Imaging of Ovarian Cancer Metastasis Post ChemotherapyR21CA256615 · NCI · THE TRUSTEES OF THE STEVENS INSTITUTE OF TECHNOLOGY · PI IWANICKI, MARCIN, WANG, SHANG · 2021 to 2022
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.